Abstract: The integration of dissimilar materials poses a significant challenge in engineering, necessitating innovative solutions for robust and reliable joining. Interlocking metasurfaces (ILMs) are a new joining technology comprising arrays of autogenous features patterned across two surfaces that interlock to form robust structural joints. The present invention is directed to optimizing the tensile performance of ILM joints formed between dissimilar materials. Parametric optimization can be used to identify optimal unit cell geometries for maximal yield strength. The invention enables the design of stronger ILM joints between dissimilar materials, thereby making ILMs a versatile and effective joining technology in diverse engineering applications.

Abstract: A manufacturing process of a concrete product includes: (1) extracting calcium from solids as portlandite; (2) forming a cementitious slurry including the portlandite; (3) shaping the cementitious slurry into a structural component; and (4) exposing the structural component to carbon dioxide sourced from a flue gas stream, thereby forming the concrete product.

Abstract: An industrial asset management system leverages augmented reality (AR) technology to discover and register assets within an industrial facility. The system uses the registered asset tracking information in conjunction with AR-based navigational features to guide users to desired assets and to provide information about an asset within the user's field of view. The asset management system also supports AR-assisted asset check in and check out workflows.

Abstract: A manufacturing process of a concrete product includes: (1) extracting calcium from solids as portlandite; (2) forming a cementitious slurry including the portlandite; (3) shaping the cementitious slurry into a structural component; and (4) exposing the structural component to carbon dioxide sourced from a flue gas stream, thereby forming the concrete product.

Abstract: Additive manufacturing (AM) can be used to fabricate a wide palette of interlocking metasurfaces (ILMs). ILMs can be architecturally tailored to achieve intentional engagement and disengagement forces, and are amenable to topological optimization. ILMs can be fabricated using nearly any AM process at different length scales according to the capabilities of the process. As a result, ILMs represent a new class of joining technology enabled by additive manufacturing that is complementary to traditional joining processes including fasteners, welds, adhesives, etc.

Abstract: A manufacturing process of a concrete product includes: (1) extracting calcium from solids as portlandite; (2) forming a cementitious slurry including the portlandite; (3) shaping the cementitious slurry into a structural component; and (4) exposing the structural component to carbon dioxide sourced from a flue gas stream, thereby forming the concrete product.

Abstract: Described are systems and methods that utilize ad campaign acquisition information and user profile data to probabilistically determine which users were acquired through which ad campaign. For example, a user probabilistic attribution score may be determined for each ad campaign for each user, and a user lifetime value may be allocated to different ad campaigns based at least in part on the determined probabilistic attribution scores.

Abstract: A manufacturing process of a concrete product includes: (1) extracting calcium from solids as portlandite; (2) forming a cementitious slurry including the portlandite; (3) shaping the cementitious slurry into a structural component; and (4) exposing the structural component to carbon dioxide sourced from a flue gas stream, thereby forming the concrete product.

Abstract: A manufacturing process of a concrete product includes: (1) extracting calcium from solids as portlandite; (2) forming a cementitious slurry including the portlandite; (3) shaping the cementitious slurry into a structural component; and (4) exposing the structural component to carbon dioxide sourced from a flue gas stream, thereby forming the concrete product.

Abstract: A manufacturing process of a concrete product includes: (1) extracting calcium from solids as portlandite; (2) forming a cementitious slurry including the portlandite; (3) shaping the cementitious slurry into a structural component; and (4) exposing the structural component to carbon dioxide sourced from a flue gas stream, thereby forming the concrete product.

Abstract: A distributed clinical trial system that provides configurability, reusability and integration of randomization and inventory configurations for different clinical trials with various electronic data capture (EDC) systems. The distributed clinical trial system includes a method of dispensing medication in a multi-arm clinical trial. In accordance with the method a subject identifier and a trial identifier are received from an electronic data capture system. The trial identifier indicates the multi-arm clinical trial, and the subject identifier indicates a subject enrolled in the multi-arm clinical trial. An arm identifier is retrieved from a database based on the received subject identifier. The arm identifier indicates an arm in the multi-arm clinical trial to which the subject is assigned. Thereafter, treatment is determined for the arm identifier based on a treatment design previously configured for the multi-arm clinical trial.

Abstract: A distributed clinical trial system that provides configurability, reusability and integration of randomization for different clinical trials with various electronic data capture (EDC) systems. The distributed clinical trial system includes a method of randomizing subjects in a multi-arm clinical trial. In accordance with a method, a subject identifier and a trial identifier are received from an EDC system. The trial identifier indicates the multi-arm clinical trial and the subject identifier indicates a subject enrolled in the multi-arm clinical trial. A randomization design algorithm for the multi-arm clinical trial is retrieved from a database using the received trial identifier. The randomization design algorithm is executed.

Abstract: A method for substantiating a data message for use in a system includes adding discovery information to the data message related to the origin of the data message, validating the data message to comply with an industry standard, authenticating the data message to determine who transmitted the data message, and authorizing the transmission of the data message based on access rights. A method for generating a substantiated system is also described.

Abstract: A system for managing clinical treatment dispensation includes a rules engine and a treatment assignment subsystem. The rules engine is capable of receiving at least two treatment parameters from at least one treatment module and uses the treatment parameters to compute a set of treatment combinations. The treatment assignment subsystem uses the treatment combinations set to generate treatment dispensation information useful for treating a patient. A method for generating a clinical treatment dispensation design is also described.

Abstract: A method for maintaining data in a substantiated state includes executing one or more services on the data message at a first node, annotating the message header with the services executed at the first node, transmitting the data message over a data network, and receiving the annotated data message at a second node. The annotation corresponds to the services executed at the first node, and the annotated data is extractable from the header for the execution of services at the second node. A system for maintaining data in a substantiated state is also described.

Abstract: A method for maintaining data in a substantiated state includes executing one or more services on the data message at a first node, annotating the message header with the services executed at the first node, transmitting the data message over a data network, and receiving the annotated data message at a second node. The annotation corresponds to the services executed at the first node, and the annotated data is extractable from the header for the execution of services at the second node. A system for maintaining data in a substantiated state is also described.

Abstract: A distributed clinical trial system that provides configurability, reusability and integration of randomization and inventory configurations for different clinical trials with various electronic data capture (EDC) systems. The distributed clinical trial system includes a method of dispensing medication in a multi-arm clinical trial. In accordance with the method a subject identifier and a trial identifier are received from an electronic data capture system. The trial identifier indicates the multi-arm clinical trial, and the subject identifier indicates a subject enrolled in the multi-arm clinical trial. An arm identifier is retrieved from a database based on the received subject identifier. The arm identifier indicates an arm in the multi-arm clinical trial to which the subject is assigned. Thereafter, treatment is determined for the arm identifier based on a treatment design previously configured for the multi-arm clinical trial.

Abstract: A distributed clinical trial system that provides configurability, reusability and integration of randomization for different clinical trials with various electronic data capture (EDC) systems. The distributed clinical trial system includes a method of randomizing subjects in a multi-arm clinical trial. In accordance with a method, a subject identifier and a trial identifier are received from an EDC system. The trial identifier indicates the multi-arm clinical trial and the subject identifier indicates a subject enrolled in the multi-arm clinical trial. A randomization design algorithm for the multi-arm clinical trial is retrieved from a database using the received trial identifier. The randomization design algorithm is executed.

Abstract: A distributed clinical trial system that provides configurability, reusability and integration of randomization and inventory configurations for different clinical trials with various electronic data capture (EDC) systems. The distributed clinical trial system includes a method of randomizing subjects in a multi-arm clinical trial. In accordance with a method, a subject identifier and a trial identifier are received from an EDC system. The trial identifier indicates the multi-arm clinical trial and the subject identifier indicates a subject enrolled in the multi-arm clinical trial. A randomization design previously configured for the multi-arm clinical trial is retrieved from a database based on the received trial identifier. The subject identifier is assigned to an arm identifier of the multi-arm clinical trial based on the randomization design. The arm identifier indicates an arm of the multi-arm clinical trial to which the subject has been assigned.

Abstract: A distributed clinical trial system that provides configurability, reusability and integration of randomization and inventory configurations for different clinical trials with various electronic data capture (EDC) systems. The distributed clinical trial system includes a method of randomizing subjects in a multi-arm clinical trial. In accordance with a method, a subject identifier and a trial identifier are received from an EDC system. The trial identifier indicates the multi-arm clinical trial and the subject identifier indicates a subject enrolled in the multi-arm clinical trial. A randomization design previously configured for the multi-arm clinical trial is retrieved from a database based on the received trial identifier. The subject identifier is assigned to an arm identifier of the multi-arm clinical trial based on the randomization design. The arm identifier indicates an arm of the multi-arm clinical trial to which the subject has been assigned.